Molecular landscape of pelvic organ prolapse provides insights into disease etiology and clues towards putative novel treatments
Kirsten B. Kluivers,
Sabrina L. Lince,
Alejandra M. Ruiz-Zapata,
Manon H. Kerkhof,
Ward De Witte,
Wilke M. Post,
Lambertus A Kiemeney,
Sita H Vermeulen,
Jelle J. Goeman,
Posted 16 Mar 2020
medRxiv DOI: 10.1101/2020.03.12.20034165
Posted 16 Mar 2020
BackgroundPelvic organ prolapse (POP) represents a major health care burden in women but its underlying pathophysiological mechanisms have not been elucidated. ObjectiveTo integrate the results from a large scale exome chip study with published genetic and expression data into a molecular landscape of POP. Design, setting, and participantsThe exome chip study was conducted in 526 women with POP and 960 healthy controls. To corroborate the findings, we analysed differential gene expression data from 12 POP patients. Vaginal fibroblasts from 4 women with POP were used to test the effect of the anti-diabetic drug metformin. Outcome measurements and statistical analysisThe exome chip study used a case-control design to identify single nucleotide variants (SNVs) associated with POP after Bonferroni correction. The molecular landscape was built using the UniProt and PubMed databases to identify functional interactions between the POP candidate genes/proteins. We performed enrichment and upstream regulator analyses of the differentially expressed genes. The effect of metformin in fibroblasts was assessed using one-sample t-test. Results and limitationsWe found significant association between POP and SNVs in 54 genes. The proteins encoded by 26 of these genes fit into a molecular landscape, together with 37 other POP candidate molecules and two POP-implicated microRNAs. This landscape is located in and around epithelial cells and fibroblasts of the urogenital tract and harbors four interacting biological processes - epithelial-mesenchymal transition, immune response, modulation of the extracellular matrix, and fibroblast function - that are regulated by sex hormones and TGFB1. Based on the landscape, we predicted and showed that metformin alters gene expression in fibroblasts of POP patients in a beneficial direction. The main limitation of our study is that we have no independent replication of the exome chip results. ConclusionsThe integrated molecular landscape of POP that we built provides insights into the biological processes underlying the disease and clues towards novel treatments. Patient summaryWe reported the first exome chip study of POP and combined the genes identified in this study with other data from the literature to build a molecular landscape of POP. This landscape will advance our understanding of the disease and may lead to novel treatments.
- Downloaded 459 times
- Download rankings, all-time:
- Site-wide: 83,362
- In obstetrics and gynecology: 93
- Year to date:
- Site-wide: 40,747
- Since beginning of last month:
- Site-wide: 18,814
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!